Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
- 31 January 1988
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 111 (1), 235-246
- https://doi.org/10.1016/0008-8749(88)90066-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986
- Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfectionNature, 1986
- High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells.The Journal of Experimental Medicine, 1986
- Reconstitution of functional receptor for human interleukin-2 in mouse cellsNature, 1985
- Functional studies on the precursors of human lymphokine-activated killer cellsCellular Immunology, 1985
- THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTOTOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTLTransplantation, 1985
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973